Please Wait...

An Intelligent Approach to Risk-Based Monitoring - On Demand Webinar

How People, Process and Tools can Improve Clinical Trial Quality

Duration: 1 hour

Complete form below to view the on-demand webinar >>

Many pharmaceutical companies are excited by the promise of Risk-Based Monitoring, but are uncertain as to how to implement such an initiative. In this insightful presentation, Courtney McBean will discuss the core principles of Risk-Based Monitoring and the key steps to Implementing an RBM program that goes beyond reducing site visits and instills a greater focus on quality in clinical trials.

The presentation will focus on the important role played by

  • People – Having the right people involved in your program is a must!
  • Process – Defining a repeatable plan is crucial – learn the 7 points that must be considered
  • Tools – Attendees will see firsthand how the right technology can help you monitor what matters, when it matters.

This is a must-see for any sponsor or CRO seeking to reduce costs, improve quality, and run more efficient clinical trials.

Courtney McBean is the Vice President of Clinical Innovation at BioClinica. She was a founder of Blueprint Clinical – the innovative company that created the Compass Intelligent Monitoring solution and was recognized by Gartner as a "2014 Cool Vendor in Life Sciences." Since BioClinica's May acquisition of Blueprint, Courtney and her team have doubled their efforts to challenge the pharmaceutical community to go beyond risk-based monitoring and embrace an Intelligent Monitoring approach to clinical trials that goes beyond reducing site monitoring visits to a focus on overall quality.

View all upcoming BioClinica webinars.

 

Please fill out the form below to view the On Demand Webinar.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (2 days ago)
#Pharma & CROs: Ck it out! Enterprise tools for site payments automation & reconciliation. https://t.co/LFri5Kv0WC
bioclinica (2 days ago)
Can having a geographically diverse network of high performing sites mean fewer sites are needed in a trial? Can ha… https://t.co/tZYvWrNzHg
bioclinica (2 days ago)
Confidence is a good thing ─ especially in the clinical supply chain for global clinical trials. Here’s how accurat… https://t.co/70VwXCwuWw
bioclinica (3 days ago)
#Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most… https://t.co/3YNpB9hTXs
bioclinica (5 days ago)
Announcing our new Chief of Staff @bioclinica Adrienne Rossi! Also welcoming President Bioclinica Site Network Eliz… https://t.co/toB9yk534k
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen